Home LiteratureArticle Details
PMID: 874083 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

The Journal of clinical investigation ·Vol. 60 ·No. 1 ·1977-07-00 ·Pages 189-96

Wasserman SI, Soter NA, Center DM, Austen KF

Abstract

Sera were obtained from the venous effluents of cold-challenged arms of patients with idiopathic cold urticaria without plasma or serum cryoproteins; these sera exhibited increased neutrophil chemotactic activity without alterations of the complement system. A two- to fourfold augmentation of the base-line neutrophil chemotactic activity of serum from the immersed extremity began within 1 min, peaked at 2 min, and returned to base-line levels within 15 min, whereas there was no change in the serum chemotactic activity in the control arm. The augmented chemotactic activity in the serum specimens from the challenged arm of each patient appeared in a high molecular-weight region, as assessed by the difference in activity recovered after Sephadex G-200 gel filtration of the paired lesional and control specimens. Sequential purification of this high molecular-weight activity by anion- and cation-exchange chromatography revealed a single peak of activity at both steps. The partially purified material continued to exhibit a high molecular weight, being excluded on Sepharose 4B, and had a neutral isoelectric point. The partially purified material showed a preferential chemotactic activity for neutrophilic polymorphonuclear leukocytes, required a gradient for expression of this function, and exhibited a capacity to deactivate this cell type. This active principle, termed high molecular-weight neutrophil chemotactic factor, exhibited a time-course of release that could be superimposed upon that of histamine and the low molecular-weight eosinophil chemotactic factor and may represent another mast cell-derived mediator.

MeSH Terms
Chemotaxis, Leukocyte Cold Temperature/adverse effects Humans Macromolecular Substances Mast Cells/metabolism Neutrophils/metabolism Urticaria/blood
Chemicals
Macromolecular Substances
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wasserman S I
Soter N A
Center D M
Austen K F
References (30)
30 references, click to expand
  1. CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.
    J Immunol. 1963 Dec;91:851-8 PMID: 14106311
  2. Precise standardization of reagents for complement fixation.
    Am J Trop Med Hyg. 1963 Jan;12:103-16 PMID: 14031993
  3. Plasma histamine concentrations in allergic diseases.
    J Allergy. 1963 Jan-Feb;34:8-15 PMID: 13969926
  4. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.
    J Exp Med. 1962 Mar 1;115:453-66 PMID: 13872176
  5. Histamine, hormones, and hypersensitivity.
    J Allergy. 1954 Mar;25(2):168-89 PMID: 13142844
  6. Passive transfer of cold urticaria.
    J Allergy. 1950 Sep;21(5):414-24 PMID: 14774055
  7. Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans.
    Ann Intern Med. 1977 Apr;86(4):415-8 PMID: 848803
  8. Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.
    J Exp Med. 1976 Dec 1;144(6):1424-37 PMID: 1003098
  9. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.
    Scand J Clin Lab Invest Suppl. 1968;97:31-50 PMID: 4179066
  10. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
    J Exp Med. 1972 Jan;135(1):81-97 PMID: 5009705
  11. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    J Exp Med. 1972 Dec 1;136(6):1564-80 PMID: 4641855
  12. Serum complement component levels in human glomerulonephritis.
    Ann Intern Med. 1971 Oct;75(4):555-60 PMID: 4106150
  13. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults.
    J Immunol. 1967 Dec;99(6):1211-6 PMID: 4168664
  14. A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.
    J Immunol. 1967 Dec;99(6):1162-72 PMID: 4168662
  15. The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.
    J Invest Dermatol. 1974 Aug;63(2):219-26 PMID: 4152325
  16. Cold urticaria. Immunologic studies.
    Am J Med. 1970 Jul;49(1):23-33 PMID: 4194010
  17. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.
    J Clin Invest. 1976 Aug;58(2):408-20 PMID: 783199
  18. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
    N Engl J Med. 1972 Oct 26;287(17):835-40 PMID: 4627271
  19. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
    N Engl J Med. 1976 Mar 25;294(13):687-90 PMID: 55969
  20. Late cutaneous allergic responses in isolated IgE-dependent reactions.
    J Allergy Clin Immunol. 1973 Jul;52(1):38-46 PMID: 4577089
  21. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    J Immunol. 1975 Jan;114(1 Pt 1):87-92 PMID: 46247
  22. In vivo studies of mediator release in cold urticaria and cholinergic urticaria.
    J Allergy Clin Immunol. 1975 Jun;55(6):394-402 PMID: 48522
  23. Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.
    Immunology. 1970 Jun;18(6):943-54 PMID: 4987909
  24. The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.
    Arthritis Rheum. 1970 Nov-Dec;13(6):713-23 PMID: 4992981
  25. Immunochemical quantitation of antigens by single radial immunodiffusion.
    Immunochemistry. 1965 Sep;2(3):235-54 PMID: 4956917
  26. The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.
    J Immunol. 1968 Jun;100(6):1154-64 PMID: 4972183
  27. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Arthritis Rheum. 1975 Jul-Aug;18(4):289-95 PMID: 808229
  28. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Proc Soc Exp Biol Med. 1975 Jan;148(1):301-6 PMID: 1129271
  29. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    J Immunol. 1969 Mar;102(3):533-43 PMID: 5813010
  30. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    J Exp Med. 1968 Apr 1;127(4):693-709 PMID: 5642465
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1977-07-00
Pages
189-96
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC372357
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com